Cargando…
SUN-248 Growth Hormone Deficiency (GHD): Assessing Burden of Treatment in Children and Adolescents
Background: Growth hormone deficiency treatment involves daily injections, which can be difficult to administer, incorporate into daily routines, and lead to poor treatment compliance. The Treatment Burden–Child Growth Hormone Deficiency (TB-CGHD) measure was developed according to FDA and EMA regul...
Autores principales: | Brod, Meryl, Højby Rasmussen, Michael, Vad, Knud, Alolga, Suzanne, Bedoin, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553403/ http://dx.doi.org/10.1210/js.2019-SUN-248 |
Ejemplares similares
-
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
por: Brod, Meryl, et al.
Publicado: (2021) -
Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB)
por: Brod, Meryl, et al.
Publicado: (2022) -
SAT-091 First Report of Disease-Specific Patient-Reported Outcomes from a Randomized Phase 2 Trial of Once-Weekly Somapacitan vs Daily GH in Children with GHD
por: Brod, Meryl, et al.
Publicado: (2020) -
Understanding burden of illness for child growth hormone deficiency
por: Brod, Meryl, et al.
Publicado: (2017) -
Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency
por: Brod, Meryl, et al.
Publicado: (2017)